Compare DexCom, Inc. (DXCM) vs Ecopetrol SA (EC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Ecopetrol SA — how do they compare? DexCom, Inc. trades at $84.46 (market cap $31.81B), while Ecopetrol SA trades at $16.93 (market cap $34.09B). The key difference: DexCom, Inc. and Ecopetrol SA are close in size by market cap, and Ecopetrol SA pays a 3.91% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Ecopetrol SA for 84 Days on average.
| DXCM | EC | |
|---|---|---|
Market Cap | $31.81B | $34.09B |
Volume | 2,861,821 | 952,204 |
Sector | Health | Energy |
52-Week High | $92.34 | $18.26 |
52-Week Low | $54.84 | $8.61 |
Typical Hold Time | 62 Days | 84 Days |
Enterprise Value | $31.26B | $62.65B |
Dividend Yield | — | 3.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 1.22% amid a bearish technical outlook. The company demonstrates strong fundamental performance with consistent earnings beats, including Q2 2026 EPS of $0.70 exceeding expectations of $0.611. Revenue growth remains robust, climbing from $2.9B in 2022 to $4.7B in 2025, while net income margins improved to 17.93%. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
Wall Street maintains a bullish stance with 81% buy ratings and a $95.07 consensus price target, representing 13% upside potential. Key risks include competitive pressures in CGM markets and reimbursement challenges. The company's strong cash flow generation and expanding market opportunity in diabetes technology support long-term growth prospects despite current technical weakness.
Ecopetrol (EC) trades at $16.94, down 0.12% with bearish technical signals. The stock shows attractive valuation metrics including P/E of 7.99 and P/S of 0.91, but faces declining revenue from $159.6B in 2022 to $119.7B in 2025. Recent management changes and board restructuring under Colombia's new government create uncertainty, while the company maintains positive cash flow from operations despite recent earnings misses.
EC presents a value opportunity with discounted multiples but faces operational headwinds. The key investment thesis balances cheap valuation against declining revenue trends and political uncertainty. Risks include continued earnings volatility and government influence, while potential upside exists if new management can stabilize operations and reverse the revenue decline trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →
